Antibody–drug conjugates (ADCs) may be a big breakthrough in gynecologic cancer treatment (II): Anti-HER2/neu
Peng‐Hui Wang, Wei‐Ting Chao, Na-Rong Lee
Topics & Concepts
HER2/neuAntibody-drug conjugateAntibodyGynecologic cancerConjugateMedicineDrugTrastuzumabPharmacologyCancerMonoclonal antibodyInternal medicineOvarian cancerImmunologyBreast cancerMathematical analysisMathematicsHER2/EGFR in Cancer ResearchOvarian cancer diagnosis and treatmentLymphoma Diagnosis and Treatment